Bluejay Diagnostics (BJDX) closed at $1.70 on November 20, 2026, down 5.6% from the previous close, on volume of 21,104 shares (30-day average 91,908).
Data as of November 20, 2026.
Bluejay Diagnostics Reports Third Quarter 2026 Financial Results and Provides Business Update
ACCESS Newswire (Thu, 12-Nov 4:30 PM ET)
Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
ACCESS Newswire (Fri, 30-Oct 10:30 AM ET)
ACCESS Newswire (Tue, 13-Oct 6:30 AM ET)
ACCESS Newswire (Tue, 6-Oct 6:30 AM ET)
Globe Newswire (Tue, 8-Sep 6:30 AM ET)
Market Chameleon (Thu, 9-Oct 5:52 AM ET)
Market Chameleon (Thu, 9-Oct 3:30 AM ET)
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.
Bluejay Diagnostics trades on the NASDAQ stock market under the symbol BJDX.
As of November 20, 2026, BJDX stock price declined to $1.70 with 21,104 million shares trading.
BJDX has a beta of 1.37, meaning it tends to be more sensitive to market movements. BJDX has a correlation of 0.02 to the broad based SPY ETF.
BJDX has a market cap of $1.90 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, BJDX traded as high as $25,024.00 and as low as $1.62.
BJDX has underperformed the market in the last year with a price return of -91.6% while the SPY ETF gained +6.9%. BJDX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -54.8% and -27.7%, respectively, while the SPY returned -9.3% and -6.2%, respectively.
BJDX support price is $1.57 and resistance is $2.03 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BJDX shares will trade within this expected range on the day.